Navigation Links
FightSMA Awards $250,000 Grant to Gene Researcher at The Ohio State University
Date:5/19/2010

FightSMA, a nonprofit dedicated to developing a treatment for the deadly childhood crippler spinal muscular atrophy (SMA), is awarding a $250,000 research grant to Dr. Brian Kaspar, a principal investigator at Nationwide Children's Hospital and associate professor of The Ohio State University.

(PRWEB) May 19, 2010 -- Richmond, Virginia-based FightSMA, a nonprofit dedicated to developing a treatment for the deadly childhood crippler spinal muscular atrophy (SMA), is awarding a $250,000 research grant to Dr. Brian Kaspar, a principal investigator at Nationwide Children's Hospital and associate professor of The Ohio State University.

The grant will support safety and toxicity studies for AAV(-9), a potential “delivery system” for gene therapy for the treatment of SMA. "Our SMA gene therapy program at Nationwide Children's Hospital and The Ohio State University continues to show great promise for treating SMA patients," said Dr. Kaspar. "With this award, we will be able to test our therapy for potential safety or toxicity issues and provide important information for the regulatory process as we advance our program to the clinic in a swift and safe manner. We are all very thankful for the support of FightSMA."

The grant has been made possible by funding both from FightSMA (www.fightsma.org) and from its associated partner organization, The Gwendolyn Strong Foundation (www.gwendolynstrongfoundation.org). “We are tremendously excited about the potential for gene therapy in SMA and our continuing collaboration with The Gwendolyn Strong Foundation and the SMA Community,” said FightSMA President Martha Slay. “Gene therapy research is a marathon run, but the work of Dr. Kaspar will advance the field significantly for SMA.”

Spinal muscular atrophy (SMA) is the leading genetic cause of infant death. SMA is caused by the absence of a gene that is critical for muscle strength, the SMN (“survivor motor neuron”) gene. That gene is absent in approximately one in 30 individuals. If both a man and woman are lacking the necessary SMN gene, the chances are 25% that any of their children will manifest SMA.

An objective of gene therapy is the restoration of the missing gene through delivery systems called “vectors.” Adeno-associated virus (AAV) is considered to be an attractive candidate for the construction of vectors.

FightSMA was created in 1991 with the mission to “strategically accelerate the development of a treatment or a cure for spinal muscular atrophy.” Working with the guidance of an international Scientific Advisory Committee, FightSMA has awarded SMA research grants at more than 40 universities and research institutions in the United States, Canada, the United Kingdom, France, and Italy. FightSMA has chapters across the United States and in Canada.

For more information, contact: www.fightsma.org or 804.515.0080

# # #

Read the full story at http://www.prweb.com/releases/spinal-muscular-atrophy/research/prweb4022064.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Pennsylvania EPA Awards Abington Memorial Hospital Funding for Green Projects
2. Michael J. Fox Foundation Awards $2.8 Million to Drive Development of Parkinsons Disease Biomarker Pipeline
3. Estes Audiology Awards Hearing Aids to Two Worthy Recipients in Central Texas
4. Ascension Health Hospital Awards Streamline Health Contract to Ensure OSHA Compliance
5. Yalumba Accepts 'New World Winery Of The Year' Award At Wine Enthusiast Magazine 2009 Awards Gala
6. Ronald McDonald House Charities(R) (RMHC(R)) Awards Nearly $3 Million to Non-Profit Organizations
7. The Kenneth Rainin Foundation Awards $457,000 in Grants to Support Dance, Theater, Film and Early Literacy in the San Francisco Bay Area
8. National Center on Minority Health and Health Disparities awards $8 million to Weill Cornell
9. World Congress Announces Affordable Innovations in Health Exhibit and Awards 2010 at 7th Annual World Health Care Congress, Calls for Submissions from Organizations Striving to Improve Global Health Care
10. Childhood Apraxia of Speech Association of North America Awards Treatment Research Grant to University of New Mexico/PROMPT Institute
11. Three Pioneering Ideas in Cancer Research Granted Prestigious Damon Runyon-Rachleff Innovation Awards
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FightSMA Awards $250,000 Grant to Gene Researcher at The Ohio State University 
(Date:1/18/2017)... ... January 18, 2017 , ... The Portee Insurance Agency, a family managed firm ... central Maryland and the DC region, is inaugurating a charity event aimed at fighting ... year, making it the #1 killer in America. However, heart disease is largely preventable, ...
(Date:1/18/2017)... ... January 18, 2017 , ... Michael ... new website for its Center for Biosimilars, announced Michael J. Hennessy Associates, Inc. ... in the field of biosimilars through thought leader interaction in, live video and ...
(Date:1/17/2017)... ... , ... January is National Stalking Awareness Month (NSAM), now in its fourteenth year, ... commit the crime of stalking, a very real danger to many in our community. ... stalking and other crimes. , “Stalking: know it. Name it. Stop it.”—so reads the theme ...
(Date:1/17/2017)... ... January 17, 2017 , ... Today, ... Dr. Carol Francis re-releases powerfully uplifting interview with medical expert and prolific author, ... endure and pass through tough times, Dr. Bernie Siegel energizes listeners to live ...
(Date:1/17/2017)... ... January 17, 2017 , ... Metro ... approach to infusing high speed technology into the fabric of an entire community. ... advancement of healthcare and wellness in a yet-to-be-named, health focused campus. Leading this ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... 2017   Seno Medical Instruments, Inc. , the ... through the development of an opto-acoustic (OA/US) imaging device, ... as SVP of Engineering. Mr. Miller previously served as ... with headquarters in Bothell, Washington . ... career to the development of innovative medical imaging products ...
(Date:1/18/2017)... -- Tarix Orphan LLC today announced that the U.S. Food ... (RPD) designation for the company,s drug candidate TXA127 for ... rare genetic skin disorder. There are currently no approved ... care. "The RPD designation for TXA127 in ... the FDA in this indication," said Richard Franklin ...
(Date:1/18/2017)... 18, 2017 After the recent election ... use of cannabis both for medical and recreational purposes are ... open to the use of cannabis, but the focus is ... Arcview Market Research, the North American legal cannabis market posted ... previous year. The research projects sales will grow at a ...
Breaking Medicine Technology: